Option chain shows key data for Kura Oncology's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Kura Oncology.

Kura Oncology (NASDAQ:KURA) Stock, Option Chain

Kura Oncology

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.

Baidu Photo by testing on Shutterstock

Earnings

Equities

News

Eurozone

Commodities

Markets

Trading Ideas

BIDU

CLCO

KURA

PYXS

QUBT

SNOW

Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results

oil-prices-5079975

Intraday Update

Crude Oil Gains 1%; Deere Posts Better-Than-Expected Earnings

Wall Street US stocks

CATX

NVDA

Dow Jumps Over 100 Points; Nvidia Posts Upbeat Earnings

Kura Oncology Inc

Kura Sushi Inc

Kura Sushi USA, Inc. - Class A Common Stock

Kura Sushi USA Inc

Kuraray Co Ltd

Baird analyst Colin Sebastian maintains Electronic Arts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EA#NASDAQ">EA</a>) with a Outperform and lowers the price target from $175 to $158.

Price Target

Analyst Ratings

Baird Maintains Outperform on Electronic Arts, Lowers Price Target to $158

Data shared from phase II NEO trial highlights Guardant Reveal&#x2122; as a decision tool to support organ preservation in rectal cancer
Guardant Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GH#NASDAQ">GH</a>), a leading precision oncology company, today announced the company and its research collaborators will present data showcasing the benefits of Guardant's precision oncology tools across cancer screening, recurrence monitoring, treatment selection and therapy development at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) in San Francisco, January 23-25, 2025.
Key focus areas in Guardant's co-authored abstracts and collaborator presentations utilizing Guardant products include the impact of mutations on treatment response in colorectal cancer and biliary tract cancers, and additional support for the benefits of blood-based screening in colorectal, gastric and esophageal cancers. A rapid oral presentation will feature data from the phase II NEO trial highlighting Guardant Reveal as a decision tool to support organ preservation in patients with node-negative rectal cancer undergoing neoadjuvant chemotherapy, excision and observation.

Biotech

General

Guardant Health Presents Phase II NEO Trial Data On Guardant Reveal Tool For Organ Preservation In Node-Negative Rectal Cancer At The ASCO GI Symposium

Citigroup analyst Andrew Kaplowitz maintains GE Vernova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) with a Neutral and raises the price target from $361 to $437.

Citigroup Maintains Neutral on GE Vernova, Raises Price Target to $437

WIIM

Sellas Life Sciences shares are trading higher after the company announced interim analysis results from its Phase 3 REGAL trial of GPS in acute myeloid leukemia.

Bolivia, the owner of the world's largest lithium reserves, is trying to capitalize on this valuable resource. Despite prices plummeting from 2022 highs, the country is pushing forward with large-scale investments to take advantage of the <a target="_blank" href="https://www.benzinga.com/topic/battery" rel="noreferrer noopener">growing battery industry</a>.
"With the two new contracts, we plan to reach 49,000 tons of lithium carbonate annually within three years," Omar Alarcon, president of Bolivia's state-owned lithium company Yacimientos de Litio Bolivianos (YLB) <a target="_blank" href="https://www.bloomberg.com/news/articles/2025-01-21/bolivia-steps-up-lithium-dealmaking-despite-growing-opposition" rel="noreferrer noopener">told</a> Bloomberg.
YLB's deals with Russia's Uranium One Group and a Chinese consortium totaling nearly $2 billion. The agreements include the construction of three processing plants. The Russian-backed facility is set to produce 14,000 tons annually, while the Chinese partnership aims to add 35,000 tons.
Despite holding an estimated 21 million tons of lithium beneath the Uyuni salt flat in the southern region of Potosí, Bolivia's current production is negligible.
Key challenges include the high altitude of its deposits, the logistical constraints of being landlocked, and a high concentration of magnesium in its brine, which complicates extraction.
Together, these hurdles make the production at current prices of around $10,000 per ton barely viable. To address these obstacles, the government is banking on direct lithium extraction technology, which promises to reduce processing times and increase efficiency.
While Bolivia's ambitions are laudable, environmental concerns loom large. Last year, Potosí Senator Elena Aguilar voiced concerns over water usage <a target="_blank" href="https://news.mongabay.com/2024/04/rapid-growth-of-bolivias-lithium-industry-creating-new-problems-for-local-communities/" rel="noreferrer noopener">for</a> Mongabay.
"We want to see the industrialization of lithium, but it has to be done responsibly for the sake of our natural resources." A 2024 inspection by the Regional Federation of Workers and Peasants of the Southern Altiplano found operational inefficiencies at existing facilities. Equipment at a lithium carbonate plant remained unpacked, and power shortages were hampering progress. Moreover, a potassium chloride plant, designed for 350,000 tons of annual production managed only 80,000 tons, raising doubts about Bolivia's industrial readiness.
Still, the industry's problems extend far beyond emerging markets. A <a target="_blank" href="https://pdf.sciencedirectassets.com/319959/1-s2.0-S2589811624X00051/1-s2.0-S2589811625000011/main.pdf" rel="noreferrer noopener">research paper</a> by Johnson, Park, and Kramarz critiques the lack of credible governance mechanisms in the lithium sector, pointing out that voluntary and hybrid regulatory measures often fail to prevent environmental harm or ensure community participation.
The authors stress that effective governance must include stringent monitoring, local engagement, and enforceable penalties for non-compliance—a long shot for a country such as Bolivia, which boasts a Corruption Perceptions Index of 29, the sixth-worst in the LATAM region.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43142099/trumps-u-turn-on-green-tech-masks-the-long-term-resource-independence-goals" target="_blank" rel="noreferrer noopener">No EV Credits, No Problem: Mining Giants Still See Green In Trump Deregulation Push</a></li>
</ul>
Photo via Shutterstock

Latin America

Financing

Bolivia Taps BRICS For Raising $2 Billion, Targets Its Vast Lithium Riches

BNZI

Banzai International shares are trading higher after the company announced the acquisition of Act-On Software.

As of Jan. 23, 2025, three stocks in the information technology sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Kopin Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOPN#NASDAQ">KOPN</a>)</h3>
<ul>
<li>Kopin shares rose sharply on Wednesday amid a report suggesting the company may be interested in competing for an Army contract. The company's stock surged around 20% over the past five days and has a <a href="https://www.benzinga.com/quote/KOPN">52-week high of $2.82</a>.</li>
<li>RSI Value: 77.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>KOPN Price Action: Shares of Kopin gained 14% to close at $1.47 on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">Guidewire Software Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>)</h3>
<ul>
<li>Guidewire Software will replace Arrowhead Pharmaceuticals in the S&amp;P MidCap 400, effective prior to opening of trading on Jan. 27. The company's stock gained around 5% over the past five days and <a href="https://www.benzinga.com/quote/GWRE">has a 52-week high</a> of $209.14.</li>
<li>RSI Value: 72.5</li>
<li>GWRE Price Action: Shares of Guidewire Software gained 1.1% to close at $183.49 on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">Himax Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIMX#NASDAQ">HIMX</a>)</h3>
<ul>
<li>On Jan. 10, Delta reported fourth-quarter adj. operating revenue growth of 5.7% year-over-year to $14.437 billion. GAAP operating revenue was $15.56 billion (+9.4% YoY), beating the consensus of $14.212 billion. The company's stock gained around 29% over the past five days and has a <a href="https://www.benzinga.com/quote/HIMX">52-week high</a> of $11.14.</li>
<li>RSI Value: 74.9</li>
<li>HIMX Price Action: Shares of Himax gained 3.8% to close at $9.92 on Wednesday.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43126364/jim-cramer-this-tech-stock-is-a-buy-amd-is-a-great-company">Jim Cramer: AMD Is A &#8216;Great&#8217; Company, Hold Onto Dow Inc.</a></li>
</ul>

Short Ideas

Pre-Market Outlook

GWRE

HIMX

KOPN

Top 3 Tech Stocks That Are Ticking Portfolio Bombs

Reinsurance Gr's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) short percent of float has risen 46.03% since its last report. The company recently reported that it has 466 thousand shares sold short, which is 0.92% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.01 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Reinsurance Gr Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737638122_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Reinsurance Gr has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Reinsurance Gr's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Reinsurance Gr's peer group average for short interest as a percentage of float is 1.75%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Peering Into Reinsurance Gr's Recent Short Interest

On Thursday, Banzai International, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNZI#NASDAQ">BNZI</a>) announced that it has signed a definitive agreement to acquire Act-On Software Inc, an enterprise marketing automation platform (MAP) provider.
The aggregate merger consideration of $53.2 million will consist of common stock and pre-funded warrants exercisable for common stock, valued at $33.2 million, and a cash consideration of $20.0 million.
Act-On is an easy-to-use, intelligent marketing automation platform powered by AI and supported by an open data architecture.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/01/43130244/amphenol-q4-earnings-30-sales-growth-ceo-highlights-growth-in-it-mobile-and-defense-markets-forecasts-strong-q1-sales-growth" rel="noreferrer noopener">Amphenol Q4 Earnings: Revenue And EPS Beat, CEO Highlights Growth In IT, Mobile And Defense, Strong Q1 Forecast And More</a>
Clients like Hitachi, BestBuy, and Progressive Insurance utilize Act-On to improve lead generation, increase sales pipeline, automate customer communications, and increase return on marketing investment (ROMI).
Banzai founder and CEO Joe Davy noted that Act-On&#8217;s software complements Banzai&#8217;s suite of tools for data-driven marketers. By making customer data actionable, Act-On empowers marketers to create smart, effective programs to drive growth and increase customer lifetime value—all with exceptional speed and efficiency, Davy added.
The acquisition is projected to increase revenue by $27 million for the twelve-month period ending December 31, 2025, on a pro forma basis.
Banzai held $4.3 million in <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g41994365/banzai-reports-third-quarter-2024-financial-results-annualized-adjusted-net-loss-improvement-of-12" rel="noreferrer noopener">cash and equivalents</a> as of September 30, 2024
Price Action: At the last check on Thursday, BNZI stock traded higher by 1.21% to $1.67 in the premarket session.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/01/43102671/comcasts-wicked-hits-700-million-worldwide-breaks-records-as-top-grossing-stage-musical-adaptation" target="_blank" rel="noreferrer noopener">Comcast&#8217;s Wicked Hits $700 Million Worldwide, Breaks Records as Top-Grossing Stage Musical Adaptation</a></li>
</ul>

Market-Moving Exclusives

Exclusives

EXCLUSIVE: Banzai To Snap Act-On Software For $53.2 Million, Expanding AI-Powered Marketing Tools for Clients Like BestBuy and Hitachi

Baker Hughes's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NYSE">BKR</a>) short percent of float has fallen 10.55% since its last report. The company recently reported that it has 13.65 million shares sold short, which is 1.78% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.4 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Baker Hughes Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737638117_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Baker Hughes has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Baker Hughes's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Baker Hughes's peer group average for short interest as a percentage of float is 8.43%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Baker Hughes?

On Thursday, La Rosa Holdings Corp (NASDAQ:&nbsp;LRHC) announced a preliminary revenue estimate of $65 million for fiscal year 2024, up 104% from the previous year.
CEO Joe La Rosa noted strategic acquisitions of real estate brokerage franchisees and a significant increase in agent count drove the performance.
Rosa expects that 2025 will be another strong year backed by its continued expansion plans.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/emerging-markets/25/01/43096797/huawei-wants-to-take-nvidias-place-in-ai-in-china-shifts-focus-to-inference-over-training" rel="noreferrer noopener">Huawei Wants To Take Nvidia&#8217;s Place In AI In China, Shifts Focus to Inference Over Training</a>
Rosa noted that the company is on track to close the previously announced acquisition of a real estate brokerage firm in the first quarter of 2025. The firm generated $19 million in revenue in 2023 and has a network of over 950 agents across multiple states.
Rosa plans to expand into new states, acquire additional real estate brokerage firms, increase agent count, and continuously enhance its technology.
Price Action: LRHC stock traded higher by 6.29% at $0.51 premarket at the last check on Thursday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/01/43095433/umc-q4-earnings-topline-rises-99-driven-by-ai-and-smartphones-projects-flat-q1-shipments" target="_blank" rel="noreferrer noopener">UMC Q4 Earnings: Topline Rises 9.9% Driven By AI And Smartphones, Projects Sequentially Flat Q1 Shipments</a></li>
</ul>

Guidance

LRHC

EXCLUSIVE: La Rosa Doubles Revenue to $65 Million in 2024, Plans Major Expansion and $19 Million Brokerage Acquisition

ZoomInfo Technologies's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZI#NYSE">ZI</a>) short percent of float has fallen 21.35% since its last report. The company recently reported that it has 25.21 million shares sold short, which is 8.07% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.47 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>ZoomInfo Technologies Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737638112_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for ZoomInfo Technologies has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing ZoomInfo Technologies's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, ZoomInfo Technologies's peer group average for short interest as a percentage of float is 6.79%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into ZoomInfo Technologies's Recent Short Interest

EXCLUSIVE: Banzai Tells Benzinga, Co Announces Acquisition Of Act-On Software For $53.2M To Enhance AI-Driven B2B Marketing Platform, Growing TTM Revenue 152% To $44M; Revenue Expected To Increase By $27M By The End Of 2025

EXCLUSIVE: La Rosa Holdings Tells Benzinga, Co. Reports Preliminary FY24 Revenue Of $65M, Up ~104% Year-Over-Year; Says "Anticipate That 2025 Will Be Another Strong Year As We Build On This Momentum With Ambitious Plans For Continued Expansion."

Solana's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) has surged 21% over the past week, driven by excitement over meme coin launches and anticipation of <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43064882/bitcoin-etfs-outperform-in-first-year-but-solana-xrp-etfs-face-challenges-expert-says">a futures ETF</a>.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$244.80</td>
<td>$119.1 billion</td>
<td>-4.6%&nbsp;</td>
<td>+21% </td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$3,208.51</td>
<td>$386.5 billion</td>
<td>-3.1%</td>
<td>-3.8%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$3.09</td>
<td>$177.7 billion</td>
<td>&nbsp;-2.6%&nbsp;</td>
<td> -2%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto trader Jelle predicts "more violent moves" ahead as Solana consolidates near its previous all-time highs.
He <a href="https://x.com/CryptoJelleNL/status/1882367467336712584">views</a> the current correction as a healthy pause after its recent rally, suggesting, "It's only a matter of time before the next leg higher."
Meanwhile, trader IncomeSharks warns that Solana memes may face another dip, citing the importance of reclaiming the $272 level for a sustained bullish move.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24SOL&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$SOL</a> &#8211; Still making lower highs. Solana memes probably have another lower flush coming. Reclaim $272 and this is invalided <a href="https://t.co/8CkorAwqqL">pic.twitter.com/8CkorAwqqL</a>
&mdash; IncomeSharks (@IncomeSharks) <a href="https://twitter.com/IncomeSharks/status/1882199521423429954?ref_src=twsrc%5Etfw">January 22, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Statistics: According to DeFiLlama, Solana's total value locked (TVL) has hit a record $11.6 billion as of today. 
On-chain revenue has also peaked at $5.9 million.
Santiment <a href="https://x.com/santimentfeed/status/1882156632110485836">data</a> reveals mixed sentiment on Solana, with a 3:2 ratio of negative vs. positive comments across platforms like X, Reddit and Telegram. 
The network's minor decoupling from other altcoins, supported by meme coin activity, has stirred retail uncertainty amid transaction delays.  
Data shows whales and sharks are accumulating SOL even as retail traders reduce their holdings.
Community News: Bloomberg's Senior ETF Analyst Eric Balchunas <a href="https://x.com/EricBalchunas/status/1882155132219216240">shared</a> that Volatility Shares is leading the race to launch a Solana Futures ETF, potentially by mid-March. 
However, Balchunas remains uncertain about sustained demand, especially with a spot ETF anticipated soon.
SolanaFloor <a href="https://x.com/SolanaFloor/status/1882156348328337897">announced </a>that CME Group will launch SOL Futures contracts on Feb. 10.
Coinbase CEO Brian Armstrong <a href="https://x.com/brian_armstrong/status/1881987902701207678">assured</a> traders that the company is scaling infrastructure to better support Solana during periods of high demand, addressing delays in activities like DEX trading and meme coin transactions. 
He stated that their goal is to provide tier 1 support for Solana, comparable to Bitcoin, Ethereum and Base, which also faced delays recently due to high activity.
Armstrong oncluded, "The surge in activity is great for the ecosystem but we need to do a better job serving our customers during periods of high demand."
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/01/43074520/solana-skyrockets-sees-15-surge-following-launch-of-trump-themed-meme-coin">Solana Skyrockets, Sees 15% Surge Following Launch Of Trump-Themed Meme Coin</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ETH

$SOL

$XRP

Solana Jumps 20% In 7 Days: Why Is SOL Going Up?

MarineMax shares are trading higher after the company reported better-than-expected Q1 adjusted EPS results.

GE Vernova Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) reported worse-than-expected fourth-quarter EPS and <a href="https://www.benzinga.com/news/earnings/25/01/43128325/ge-vernova-mixed-q4-revenue-misses-but-orders-surge-22-amid-strong-electrification-demand">revenue on Wednesday</a>.
The company reported revenue growth of 5% year-over-year to $10.559 billion and +9% organically, missing the consensus of $10.78 billion.
The company achieved orders totaling $13.2 billion, reflecting a 22% organic increase, ~1.3 times revenue, driven primarily by Power and Electrification equipment. Earnings per share for the quarter were $1.73, compared to $0.72 a year ago, missing the consensus of $2.55.
"GE Vernova built a strong foundation in 2024 with solid orders and revenue growth, as well as significant margin expansion and cash generation. We saw strength in Power and Electrification and improvement in Wind, while growing our equipment backlog at better margins," stated GE Vernova CEO Scott Strazik.
GE Vernova reaffirms its 2025 outlook with $36 billion – $37 billion in revenue versus a consensus of $36.88 billion, a high single-digit adjusted EBITDA margin, and $2 billion – $2.5 billion in free cash flow.
GE Vernova shares gained 2.7% to close at $427.10 on Wednesday.
These analysts made changes to their price targets on GE Vernova following earnings announcement.
<ul>
<li>JP Morgan analyst Mark Strouse maintained GE Vernova with an Overweight and raised the price target from $374 to $436.</li>
<li>Barclays analyst Julian Mitchell maintained the stock with an Overweight and raised the price target from $420 to $487.</li>
</ul>
Considering buying GEV stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="489" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23081255/image-174-1024x489.png" alt="" class="wp-image-746761" style="width:565px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23081255/image-174-1024x489.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23081255/image-174-300x143.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23081255/image-174-768x367.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23081255/image-174.png 1111w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43126364/jim-cramer-this-tech-stock-is-a-buy-amd-is-a-great-company">Jim Cramer: AMD Is A &#8216;Great&#8217; Company, Hold Onto Dow Inc.</a></li>
</ul>

GE Vernova Analysts Boost Their Forecasts After Strong Q4 Results

GE Aerospace CFO Says In 2025, Do Think Spare Parts To Stay Strong

EVTL

Vertical Aerospace shares are trading lower after the company announced a $90 million public offering.

SELLAS Life Sciences Announces Interim Analysis For Phase 3 REGAL Trial Of GPS In Acute Myeloid Leukemia Showing; Says Independent Data Monitoring Committee Recommended Trial Continue Without Modifications

Press Releases

Cartography Announces Appointment of Troy Wilson, Ph.D., J.D., to its Board of Directors

Kura Oncology to Report Third Quarter 2024 Financial Results

Health Care

Kura Oncology to Present Updated Data from KOMET-007 Combination Trial of Ziftomenib at ASH Annual Meeting

Kura Oncology Reports Third Quarter 2024 Financial Results

Contracts

Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias

Kura Oncology to Participate in JMP Securities Hematology and Oncology Summit

Kura Oncology to Host Virtual Investor Event on December 9, 2024

Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting

Comments

Kura Oncology

Kura Oncology (KURA) Options

Loading...

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga